drugset / Trial / NCT00768690

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333

NCT00768690

Phase 1 Completed 45 enrolled Abbott
RandomizedSingle-groupTriple-blind

Summary

The purpose of this study is to determine multiple dose safety, tolerability and pharmacokinetics of ABT-333 under nonfasting conditions in healthy adult subjects, and to determine the effect of single dose administration of ketoconazole on steady state ABT-333 pharmacokinetics

Timeline

Start
2008-10
Primary completion
2009-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 400 mg
Subject dasabuvir Small molecule 200 mg
Subject dasabuvir Small molecule 400 mg
Subject dasabuvir Small molecule 600 mg
Subject dasabuvir Small molecule 1000 mg